This week, we’ll focus on two recent approvals from the U.S. Food and Drug Administration in patients with leukemia and lymphoma, respectively.

Coverage of stories discussed this week on ascopost.com:

FDA Approves Venetoclax Combination Regimen for Certain Adult Patients With AML

FDA Extends the Approval of Pembrolizumab for Patients With Classical Hodgkin Lymphoma

To listen to more podcasts from ASCO, visit asco.org/podcasts.